Evaluation of the effects of therapeutic and supra-therapeutic single doses of SKY0402 [bupivacaine] given as subcutaneous injection on the QT/QTc interval in young healthy volunteers. A prospective, randomized, placebo- and positive-controlled, double blind, single-centre, crossover phase 1 study.
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2010
At a glance
- Drugs Bupivacaine; Moxifloxacin
- Indications Bacterial infections; Postoperative pain
- Focus Adverse reactions
- 18 Sep 2007 Status changed from recruiting to completed.
- 04 Aug 2007 New trial record.